Skip to content

Manchester vascular access study

Understanding haemodialysis vascular access maturation: a prospective observational study to understand the natural history and biology of AV access maturation and identify risk factors for AVF failure

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN57422410
Enrollment
250
Registered
2014-04-03
Start date
2011-10-20
Completion date
Unknown
Last updated
2020-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Renal disorders

Interventions

Extra bloods at baseline: Patients will have an extra blood test at this point for haematological/biochemical parameters and DNA/stem cell sampling and analysis. Extra blood tests will be optional and
blood tests will be optional and are not mandatory for study inclusion. US scan - follow-up, Doppler ultrasound scan will be used to assess maturation. It is anticipated that most pat

Sponsors

Central Manchester & Manchester Childrens University Hospital NHS Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The participant is in need of AV dialysis access for haemodialysis. 2. Participant is available and can return for follow-up visits Target Gender: Male & Female ; Lower Age Limit 18 years

Exclusion criteria

Exclusion criteria: Inability to give consent and comply with the study follow-up schedule

Design outcomes

Primary

MeasureTime frame
Successful (unassisted) maturation defined as either A or B A: Use of the AVF with two needles

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026